1. Scrip

Takeda To Build On COVID-19 Awareness For Its Dengue Vaccine

TAK-003 Could Be Blockbuster

 
• By Andrew McConaghie

Takeda’s vaccines chief Rajeev Venkayya tells Scrip about its COVID-19 vaccines partnerships, and how the pandemic can stimulate action against other infectious disease threats such as Dengue.

Fumigation against Dengue and malaria in Mumbai, India, 2020.
Fumigation to target the mosquito carriers, as pictured here in Mumbai, remains vital against Dengue in the absence of a widely available vaccine. • Source: Getty Images

Takeda’s vaccines business could be a big part of the company’s future growth thanks to a promising late-stage Dengue vaccine candidate and partnerships with Moderna and Novavax on their COVID-19 shots in Japan.

And Rajeev Venkayya, president of Takeda’s global vaccine business unit has told Scrip that the devastation caused by the COVID-19 pandemic could help galvanize the world

More from COVID-19

More from Scrip